Beam Therapeutics
NASDAQ: BEAM
$25.18
as on
Beam Therapeutics Stock Performance
as on September 10, 2026 at 2:15 pm IST
Day's Low
Day's High
$25.11$26.64
0.28%
Downside
5.80%
Upside
52 Week's Low
52 Week's High
$19.36$38.2623.13%
Downside
51.95%
Upside
Beam Therapeutics share price movements today
- Previous Close
- $26.83
- Open
- $26.64
- Volume
- 2.4M
- Market Cap
- $3.1B
- Day's Low - High
- $25.11 - $26.64
- 52 Week Low - High
- $19.36 - $38.26
Beam Therapeutics Historical Returns
- 1 Month Return
- -2.37 %
- 3 Month Return
- -11.95 %
- 1 Year Return
- + 31.75 %
- 3 Year Return
- + 5.01 %
- 5 Year Return
- -75.16 %
Beam Therapeutics Stock Fundamentals & Key Indicators
Check Beam Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$3.1B
EPS (TTM)
-4.4535
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
0PEG Ratio
0EBITDA
-355.8M
Revenue (TTM)
156.0M
Profit Margin
-55.45%
Return On Equity TTM
-8.18%
Beam Therapeutics vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Beam Therapeutics with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % | Dividend Yield % |
|---|---|---|---|---|---|---|
| BUY | $3.1B | -75.16% | NA | -55.45% | NA | |
| BUY | $44.6B | 614.61% | NA | 0.00% | NA | |
| BUY | $138.4B | 181.2% | 30.54 | 86.04% | NA | |
| BUY | $58.1B | -69.22% | -17.59 | -12.57% | NA | |
| BUY | $85.2B | 25.41% | 19.35 | 84.86% | 0.45999999999999996% |
Stock Returns calculator for Beam Therapeutics Stock including INR - Dollar returns
The Beam Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Investment Value
₹1,00,000
Beam Therapeutics investment value today
Current value as on today
₹1,33,251
Returns
₹33,251
(+33.25%)
Returns from Beam Therapeutics Stock
₹23,644 (+23.64%)
Dollar Impact
₹9,607 (+9.61%)
Analyst Recommendation on Beam Therapeutics Stock
Based on 11 analysts
90.91%
Buy
9.09%
Hold
0.00%
Sell
Based on 11 analysts, 90.9090909090909% of analysts recommend a 'BUY' rating for Beam Therapeutics. Average target price of $52.15
Beam Therapeutics Share Price Target
Get share price movements and forecasts by analysts on Beam Therapeutics.
What analysts predicted
51.72%UPSIDE
Target Price
$52.15
Current Price
$25.18
Analyzed by
11 Analysts
Target
$52.15
Beam Therapeutics target price $52.15, a slight upside of 51.72% compared to current price of $25.18. According to 11 analysts rating.
Indian Investors' Interest in Beam Therapeutics Stock
Investment in Beam Therapeutics Shares on INDmoney has dropped by -42.91% in the last 30 days, indicating reduced investment activity.
Time period: to
Search interest for Beam Therapeutics Stock has increased by 8% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:8% versus previous 30 day period
Beam Therapeutics Quarterly Profit & Loss
All numbers in Millions USD
Beam Therapeutics Annual Profit & Loss
All numbers in Millions USD
Beam Therapeutics Quarterly Cash Flow
All numbers in Millions USD
Beam Therapeutics Annual Cash Flow
All numbers in Millions USD
Beam Therapeutics News & Key Events
Today's Timeline - 01 September
Tue, 04:30 PM
-Beam Therapeutics appoints Eric Foster as chief commercial officer to lead commercial strategy for upcoming product launches.
Insights on Beam Therapeutics
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
NO EFFECTAgainst Peers
In the last 3 years, Revolution Medicines, Inc. Common Stock has given 26.0% return, outperforming this stock by 27.5%
- NO EFFECT
Against Peers
In the last 1 year, Moderna, Inc. Common Stock has given 457.8% return, outperforming this stock by 431.2%
NEGATIVE IMPACTPrice Dip
In the last 7 days, BEAM stock has moved down by -14.5%
- NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 3 quarters, 244.29M → -122.67M (in $), with an average decrease of 84.3% per quarter
- NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 3 quarters, 114.10M → 490.0K (in $), with an average decrease of 85.3% per quarter
About Beam Therapeutics
| Organisation | Beam Therapeutics |
| Headquarters | 238 Main Street, Cambridge, MA, United States, 02142 |
| Industry | Biotechnology |
| CEO | Mr. John M. Evans M.B.A. |
| E-voting on shares | Click here to vote |
Key Management of Beam Therapeutics
Name | Title |
|---|---|
Dr. Christine P. Bellon J.D., Ph.D. | Chief Legal Officer & Corporate Secretary |
Dr. Amy Simon M.D. | Chief Medical Officer |
Ms. Bethany J. Cavanagh M.B.A. | Senior VP of Finance, Treasurer & Principal Accounting Officer |
Dr. Feng Zhang Ph.D. | Co-Founder |
Dr. David R. Liu Ph.D. | Co-Founder |
Dr. J. Keith Joung M.D., Ph.D. | Co-Founder |
Dr. Manmohan Singh Ph.D. | Chief Technology Officer |
Mr. John M. Evans M.B.A. | CEO & Director |
Dr. Giuseppe Ciaramella Ph.D. | President |
Mr. Sravan Kumar Emany | Chief Financial Officer |
FAQs
What is Beam Therapeutics share price today?
Beam Therapeutics share price today is $25.18 as on at the close of the market. Beam Therapeutics share today touched a day high of $26.64 and a low of $25.11.
What is the 52 week high and 52 week low for Beam Therapeutics share?
Beam Therapeutics share touched a 52 week high of $38.26 on and a 52 week low of $19.36 on . Beam Therapeutics stock price today i.e. is closed at $25.18,which is 34.19% down from its 52 week high and 30.10% up from its 52 week low.
What is Beam Therapeutics's market capitalisation today?
Beam Therapeutics market capitalisation is $0.00T as on .
How to invest in Beam Therapeutics Stock (BEAM) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Beam Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Beam Therapeutics Shares that will get you 0.0596 shares as per Beam Therapeutics share price of $25.18 per share as on September 10, 2026 at 8:45 am IST.
What is the minimum amount required to buy Beam Therapeutics Stock (BEAM) from India?
Indian investors can start investing in Beam Therapeutics (BEAM) shares with as little as ₹95.105 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹951.05 in Beam Therapeutics stock (as per the Rupee-Dollar exchange rate as on ).
Based on Beam Therapeutics share’s latest price of $25.18 as on September 10, 2026 at 8:45 am IST, you will get 0.3971 shares of Beam Therapeutics. Learn more about
fractional shares .
What are the returns that Beam Therapeutics has given to Indian investors in the last 5 years?
Beam Therapeutics stock has given -75.16% share price returns and 28.48% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?